Innovative technologies like mRNA vaccines, currently being investigated, may be critical in the fight against #COVID19 — watch to learn more.
Qu Biologics has developed a transformative first-in-class immunotherapy platform, Site Specific Immunomodulators (SSIs), that arms our first line of defense against infectious and non-infectious threats. SSIs are uniquely positioned to be implemented at the time of first emergence of a…
A new study has found that post-Covid-19 infection, antibody response actually scales down instead of building immunity over time. This was witnessed more among the elderly group than other groups. The researchers at Imperial College in London tested more than…